YAP/TAZ facilitate tumorigenesis in Ras-driven cancers [188,189], possibly via regulation of overlapping, downstream transcriptional targets [197], and can act as a surrogate for oncogenic Ras in vitro when KRAS is suppressed in cell lines from a range of cancer types [198]. Here, YAP1 is linked to cancer.